Media
311 Articles
According to Reuters, retail sales will probably drop further after the holidays. Reuters reports that the shock waves of the…
The Massachusetts Department of Public Health funded a study which is showing further evidence to support the use of drug…
The stent business in the US has been dying and it is in trouble overseas. Stents are small mesh tubs…
There is one critical aspect to the stock market that pertains to American International Group (NYSE: AIG) which has been…
Investors have another reason to bail out of Boston Scientific (BSX). It has been in a battle with the medical…
We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and…
According to Reuters, US stock indices entered a bear market phase. Reuters writes that Yahoo! (YHOO) and Microsoft (MSFT) are…
With the trading year almost half over and results from the first quarter out, 24/7 Wall St. has created the…
Boston Scientific (BSX) has been the "gang who couldn’t shot straight" of the medical device business for some time. It…
These are ten of the impact analyst calls we are seeing this Friday morning: Abbott Labs (NYSE: ABT) started as…
Thursday after the close, we’ll get to see earnings out of Genentech (NASDAQ: DNA). The estimates from First Call are…
These are the top analyst calls we are focusing on early this Thursday morning in pre-market trading: Abbott Laboratories (NYSE:…
Medtronic, Inc. (NYSE: MDT) has just announced that it has received formal approval from the FDA to market its Endeavor…
We are full fledged into earnings season now, so most news coverage will point to the current earnings environment and…
James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad…
Our top personal finance-related articles today. Your wallet will thank you later.